I2PETHV - Quantification and Localisation of Imidazoline2 Binding Sites in Healthy Volunteers Using [11C]BU99008 a Positron Emission Tomography Study
Phase of Trial: Phase 0
Latest Information Update: 17 Aug 2016
At a glance
- Drugs BU 99008 (Primary) ; Idazoxan; Isocarboxazid
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Acronyms I2PETHV
- 17 Aug 2016 Status changed from active, no longer recruiting to completed.
- 16 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 16 Feb 2016 Planned end date changed from 1 Jan 2016 to 1 Jul 2016, as reported by ClinicalTrials.gov.